AVITA Medical, Inc. (ASX:AVH)
Australia flag Australia · Delayed Price · Currency is AUD
1.265
-0.035 (-2.69%)
At close: Mar 13, 2026

AVITA Medical Statistics

Total Valuation

AVITA Medical has a market cap or net worth of AUD 192.51 million. The enterprise value is 232.30 million.

Market Cap 192.51M
Enterprise Value 232.30M

Important Dates

The next estimated earnings date is Thursday, May 7, 2026.

Earnings Date May 7, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +7.64%
Shares Change (QoQ) +7.01%
Owned by Insiders (%) 1.14%
Owned by Institutions (%) 16.00%
Float 30.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.79
PB Ratio -7.71
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -3.19
EV / Sales 2.27
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -4.81

Financial Position

The company has a current ratio of 0.57

Current Ratio 0.57
Quick Ratio 0.44
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -1.43
Interest Coverage -5.12

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -39.06%
Return on Invested Capital (ROIC) -66.56%
Return on Capital Employed (ROCE) 676.75%
Weighted Average Cost of Capital (WACC) 14.22%
Revenue Per Employee 475,034
Profits Per Employee -322,308
Employee Count 226
Asset Turnover 1.05
Inventory Turnover 1.80

Taxes

In the past 12 months, AVITA Medical has paid 16,491 in taxes.

Income Tax 16,491
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -53.32% in the last 52 weeks. The beta is 1.81, so AVITA Medical's price volatility has been higher than the market average.

Beta (5Y) 1.81
52-Week Price Change -53.32%
50-Day Moving Average 1.21
200-Day Moving Average 1.39
Relative Strength Index (RSI) 48.52
Average Volume (20 Days) 396,662

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 16.83

Income Statement

In the last 12 months, AVITA Medical had revenue of AUD 107.36 million and -72.84 million in losses. Loss per share was -2.61.

Revenue 107.36M
Gross Profit 88.18M
Operating Income -63.77M
Pretax Income -72.83M
Net Income -72.84M
EBITDA -60.33M
EBIT -63.77M
Loss Per Share -2.61
Full Income Statement

Balance Sheet

The company has 27.26 million in cash and 69.04 million in debt, with a net cash position of -41.77 million.

Cash & Cash Equivalents 27.26M
Total Debt 69.04M
Net Cash -41.77M
Net Cash Per Share n/a
Equity (Book Value) -24.96M
Book Value Per Share -0.82
Working Capital -40.76M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -46.77 million and capital expenditures -1.51 million, giving a free cash flow of -48.27 million.

Operating Cash Flow -46.77M
Capital Expenditures -1.51M
Free Cash Flow -48.27M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 82.13%, with operating and profit margins of -59.40% and -67.85%.

Gross Margin 82.13%
Operating Margin -59.40%
Pretax Margin -67.83%
Profit Margin -67.85%
EBITDA Margin -56.19%
EBIT Margin -59.40%
FCF Margin n/a

Dividends & Yields

AVITA Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.64%
Shareholder Yield -7.64%
Earnings Yield -37.84%
FCF Yield -25.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on June 24, 2020. It was a reverse split with a ratio of 0.05.

Last Split Date Jun 24, 2020
Split Type Reverse
Split Ratio 0.05

Scores

AVITA Medical has an Altman Z-Score of -10.49 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -10.49
Piotroski F-Score 2